Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/ELOX/Capital expenditures

ELOXX PHARMACEUTICALS, INC. (ELOX) Capital expenditures 2016–2022

ELOXX PHARMACEUTICALS, INC. (ELOX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$66,000FY2022 · since FY2016: $2,500 → $66,000
161718192122
Fiscal yearValueYoY
FY2022$66,000-25.8%
FY2021$89,000—
FY2019$40,000-83.0%
FY2018$235,000-0.8%
FY2017$237,000+9380.0%
FY2016$2,500—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More ELOX financial trends

ELOX RevenueELOX Net incomeELOX Net marginELOX Gross profitELOX Gross marginELOX Operating incomeELOX Operating marginELOX Operating cash flowELOX Free cash flowELOX Return on equityELOX Stock buybacksELOX Dividends paidELOX Total assetsELOX Total liabilitiesELOX Shareholders’ equityELOX overview →